FDA Updates Guidance On Unique Device Identification Labeling For Class I Devices
The US FDA’s most recent guidance revises UDI requirements for class I and unclassified medical devices the agency issued in July. Class I devices categorized as consumer health products will be exempt from some submission requirements.
You may also be interested in...
Due to the ongoing coronavirus crisis, regulators have put pushed back deadlines for meeting UDI requirements. In some instances, they will no longer require direct-mark UDI information if it can be garnered from other data on the device.
The Affordable Care Act requires health insurers to cover contraceptives; some lawmakers in the US House want to make sure those requirements are upheld.
The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.